Scotts Miracle-Gro Price Target Rises to $75; Incentive Plan Expanded by 2.75M Shares
On February 17, Wells Fargo raised its price target on Scotts Miracle-Gro to $75 from $70, maintaining an Overweight rating based on record relative Staples sector momentum versus the S&P 500. At its January 26 virtual annual meeting, shareholders approved an amendment to the Long-Term Incentive Plan expanding the share grant pool by 2,750,000 shares and implemented new RSU, performance unit and stock option agreements starting January 30.
1. Price Target Increase
On February 17, Wells Fargo raised its price target on Scotts Miracle-Gro to $75 from $70 and maintained an Overweight rating. The firm cited one of the strongest relative starts for Staples versus the S&P 500 on record and refreshed targets to reflect broader sector momentum.
2. Annual Meeting Governance Actions
At the January 26, 2026 virtual annual meeting, shareholders representing approximately 91% of outstanding shares approved an amendment to the Long-Term Incentive Plan, increasing the share grant pool by 2,750,000 common shares. Attendees also re-elected four directors through the 2029 annual meeting, approved executive compensation on an advisory basis, and ratified Deloitte & Touche LLP as the independent auditor for fiscal 2026.
3. Equity-Based Compensation Implementation
Beginning January 30, 2026, the company implemented new standardized equity award agreements, including restricted stock units, performance units and nonqualified stock options for employees and named executive officers, as well as restricted stock units and deferred stock units for non-employee directors. These measures aim to align management and board incentives with long-term shareholder value creation.